Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder
NCT ID: NCT06441864
Last Updated: 2025-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2024-07-15
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatments for Insomnia: Mediators, Moderators and Quality of Life
NCT02117388
Non-Pharmacological Treatments for Insomnia in Chronic Traumatic Brain Injury
NCT03261674
Impact of Cognitive Behavioral Therapy on Parasomnias
NCT04633668
Stabilizing Behavioral Rhythms to Improve Mental Health
NCT03152864
Behavioral Intervention for Insomnia in Older Adults
NCT01154023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2-week baseline
Participants will receive treatment after a 2-week baseline assessment period
Cognitive Behavioral Therapy for Nightmares
The intervention will consist of 7 therapy sessions (once per week for 7 weeks) which will be delivered via videoconference. Partners will attend 2 of the 7 treatment sessions. During the sessions, participants will learn techniques for managing and changing nightmares.
4-week baseline
Participants will receive treatment after a 4-week baseline assessment period
Cognitive Behavioral Therapy for Nightmares
The intervention will consist of 7 therapy sessions (once per week for 7 weeks) which will be delivered via videoconference. Partners will attend 2 of the 7 treatment sessions. During the sessions, participants will learn techniques for managing and changing nightmares.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Behavioral Therapy for Nightmares
The intervention will consist of 7 therapy sessions (once per week for 7 weeks) which will be delivered via videoconference. Partners will attend 2 of the 7 treatment sessions. During the sessions, participants will learn techniques for managing and changing nightmares.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 or older
* Speak, read, and write English
* Live in the United States
* Nightmare frequency ≥3 times per week
* Disturbing Dream and Nightmare Severity Index score indicative of nightmare disorder
* Sleep, neurological, and psychiatric medications stable for at least 1 month and willing to keep medications stable through the course of the study
* Live with a romantic partner who is willing to participate in the study
* Live with a romantic partner who meets all of the above criteria
* Age 18 or older
* Speak, read, and write English
* Live in the United States
Exclusion Criteria
* Narcolepsy
* Posttraumatic stress disorder
* Previous behavioral treatment for nightmares
* Currently engaged in sleep- or trauma-focused psychotherapy
* Taking a medication that could cause RBD, if the medication was started prior to onset of RBD symptoms
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Utah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Utah
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-SRG-23
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
00187090
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.